These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 110385)

  • 1. Behavioural effects of chronic amphetamine and their reversal by haloperidol in the marmoset [proceedings].
    Baker HF; Ridley RM
    Br J Pharmacol; 1979 May; 66(1):146P-147P. PubMed ID: 110385
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of (+)-amphetamine and apomorphine on visually determined behaviour in the marmoset [proceedings].
    Ridley RM
    Br J Pharmacol; 1978 Jun; 63(2):382P-383P. PubMed ID: 96900
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset.
    Scraggs PR; Ridley RM
    Psychopharmacology (Berl); 1979 Mar; 62(1):41-5. PubMed ID: 155838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
    Ridley RM; Crow TJ
    Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
    [No Abstract]   [Full Text] [Related]  

  • 5. The time course of the behavioral effects of amphetamine and their reversal by haloperidol in a primate species.
    Ridley RM; Baker HF; Scraggs PR
    Biol Psychiatry; 1979 Oct; 14(5):753-65. PubMed ID: 115505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of amphetamine in a small primate: relative potencies of the d- and l-isomers.
    Scraggs PR; Ridley RM
    Psychopharmacology (Berl); 1978 Dec; 59(3):243-5. PubMed ID: 104327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of intracerebral amphetamine in the marmoset.
    Annett LE; Ridley RM; Gamble SJ; Baker HF
    Psychopharmacology (Berl); 1983; 81(1):18-23. PubMed ID: 6415726
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine.
    Yehuda S; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):118-22. PubMed ID: 4367895
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of apomorphine and haloperidol: effects on locomotion and other behaviour in the marmoset.
    Scraggs PR; Baker HF; Ridley RM
    Psychopharmacology (Berl); 1979; 66(1):41-3. PubMed ID: 120540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of d-amphetamine on schedule-controlled key pressing and drinking in the chimpanzee.
    Byrd LD
    J Pharmacol Exp Ther; 1973 Jun; 185(3):633-41. PubMed ID: 4197278
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 14. The modification of drug effects on behavior by external discriminative stimuli.
    Laties VG
    J Pharmacol Exp Ther; 1972 Oct; 183(1):1-13. PubMed ID: 5080032
    [No Abstract]   [Full Text] [Related]  

  • 15. An analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol.
    Ridley RM; Haystead TA; Baker HF
    Pharmacol Biochem Behav; 1981 Mar; 14(3):345-51. PubMed ID: 6785766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice.
    Moreira FA; Guimarães FS
    Eur J Pharmacol; 2005 Apr; 512(2-3):199-205. PubMed ID: 15840405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the behavioural effects of amphetamine by a GABA agonist in a primate species.
    Ridley RM; Scraggs PR; Baker HF
    Psychopharmacology (Berl); 1979 Aug; 64(2):197-200. PubMed ID: 115041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavior as a stimulus: joint effects of d-amphetamine and pentobarbital.
    Branch MN
    J Pharmacol Exp Ther; 1974 Apr; 189(1):33-41. PubMed ID: 4823297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.